Zoa Cell’s Science Advisory Council members are among an elite few scientists with
firsthand knowledge of the new direction in medicine -- the use of adult stem cells
(ASC), also known as repair stem cells (RSC) to treat dozens of diseases, including
several diseases once considered incurable. The Council will provide independent,
advanced scientific guidance on a wide range of scientific and medical issues, including
research, technology, and industry trends.
Their oversight assures that our patient trials are held to the high standards to
which each member is accustomed, and that each goal is carefully identified and
pursued. The Council will assist in educating governments and the general public
about Zoa Cell’s capabilities, and in fostering relationships with medical societies,
individual physicians, and scientists.
Roberto J. F. Viña, MD
One of the most brilliant and successful Zoa Cell researchers and therapists, Dr.
Fernandez Viña has literally been a world pioneer in developing ASC therapies for
the related diseases of heart, Type 2 Diabetes, and now Type 1 Diabetes.
He joined with other pioneers in 2003-04 to prove the great healing benefit of Adult
Stem Cells (ASC) for heart patients in South American clinical trials, before the
USA even approved its first ever ASC human clinical trial. He is the foremost authority
in the world on the utilization of bone marrow treatment of Type 2 Diabetes and
is the first and only person with a successful clinical trial on treating Type 2
Diabetes with Adult Stem Cells. He has treated hundreds of patients with ASC, both
in his clinic in Argentina and in clinics in other Latin American countries, for
Heart Disease, Type 2 Diabetes and Emphysema. He is on the verge of another breakthrough
for the most difficult to treat common disease of all: Type 1 Diabetes.
for CURRICULUM VITAE (ENGLISH)
for Full CURRICULUM VITAE (SPANISH)
Shimon Slavin, MD
Dr. Slavin serves as the Medical & Scientific Director of the newly established
International Center for Cell Therapy & Cancer Immunotherapy(CTCI) at Top Ichilov
at the Weizman Center, Tel Aviv Medical Complex. The center attracts patients with
cancer and other diseases treatable by stem cells or immunotherapy and training
medical teams from all over the world. More recently, the center is also involved
in developing new approaches for the use of autologous bone marrow derived mesenchymal
stromal cells for regenerative medicine, attempting to Adult cartilage and regeneration
of bones and in the near future also applying stem cell therapy for experimental
treatment of cardiovascular disorders and Adult of neurological disorders including
lower motor neuron diseases and multiple sclerosis in addition to immune regulation
of other autoimmune disease.
Dr. Slavin is an honorary member of the Argentinian Academy of Science and has been
awarded many international awards for medical achievements. Slavin served until
recently as the Medical Director of Cancer Immunotherapy at the Cancer Treatment
Centers of America (CTCA) based in Chicago. He is the author of 650 scientific publications
and four books. In 2002 his published paper describing curing a three-year-old bubble
baby with cellular therapy took the world by storm. It hasn't been matched to this
In 1978, Dr. Slavin opened Israel's first bone marrow transplantation (BMT) unit,
officially recognized as Israel's National Bone Marrow Transplantation Center. For
the past 30 years he served as the Director of The Department of Stem Cell Transplantation
& Cancer Immunotherapy of the Hadassah Medical Center in Jerusalem.
Dr. Slavin has served as a visiting professor at SouthWestern University of Dallas
at Texas and the University of Minneapolis at Minnesota. He has also helped establish
many transplant centers worldwide.
Upon graduating from Hadassah Hebrew University School of Medicine in Jerusalem
in 1967 he served as the doctor of the Frogman Unit in the Israeli Navy until 1970.
He specialized in internal medicine (1970-1975) and subsequently specialized in
clinical immunology at Stanford University, Palo Alto, California and the Bone Marrow
Transplant Center at the Fred Hutchinson's Cancer Research Center, Seattle, Washington
for three years.
for CURRICULUM VITAE
Bernard P. Shagan MD, F.A.C.P.
After graduating from the New York City public school system, Dr. Shagan attended
Harvard College from which he graduated with honors in 1956. He then went on to
Medical School at New York University Bellevue Medical Center and graduated as a
member of the medical honor society, Alpha Omega Alpha in 1960. His internship and
residency in internal medicine were served at Maimonides Hospital in Brooklyn, NY
and his fellowships in Endocrinology and Metabolism at New York University and New
York Hospital Cornell Medical Center. He is board certified in Internal Medicine
and Endocrinology and Metabolism. He has been Chief of Endocrinology at several
hospitals and at East Tennessee State College of Medicine in Johnson City, Tennessee.
Dr. Shagan is a member of the faculty and co-section head of the Section of Endocrinology
of the Department of Medicine at Monmouth Medical Center. He is Clinical Professor
of Medicine at Drexel University College of Medicine. He was Chair of the Department
of Medicine at Monmouth Medical Center from 1987 to 1996 and retired from his private
practice in endocrinology and metabolism in 2004. Dr. Shagan has published in endocrinology
and is member of the editorial board of Diabetes Self Management. His landmark paper,
“Does Anyone Here Know How to Make Insulin Work Backwards?” was instrumental in
eliminating sliding scale insulin treatment from several institutions. He has published
several other papers on diabetes, thyroid disease and medical education. He has
lectured on diabetes throughout much of the United States. He received awards for
achievement in academic performance and teaching and has been listed as one of America’s
Best Physicians and “Top Docs in New Jersey.” Dr. Shagan was Governor of the ACP
New Jersey Chapter from 1996 to 2000. He received the 2004 New Jersey Laureate Award.
He is to be elected to Mastership in the American College of Physicians which will
be presented to him in April, 2009.
for CURRICULUM VITAE
Saengsuree Jootar, MD
Professor Jootar obtained her MD from the Faculty of Medicine at Ramathibodi Hospital,
Thailand in 1971, and followed this with an internship until 1972. Between 1972
and 1973, Professor Jootar also took up an internship at St Louis City Hospital,
St Louis, Missouri, USA, after which she embarked on a residency at the prestigious
Beth Israel Medical Center, New York, USA, until 1975. From 1975 to 1977, Professor
Jootar undertook a Fellowship in hematology at Vanderbilt University Hospital, Nashville,
Tennessee, USA. Professor Jootar is board-certified in internal medicine and in
Professor Saengsuree Jootar was the Chair of the Department of Medicine, Faculty
of Medicine, Mahidol University, Bangkok, Thailand during 2004-2006. She is also
the Director of the Bone Marrow Transplantation Program at the same institute for
the last 20 years.
In addition to her professional post, professor Jootar was the President of the
Thai Society of Hematology during 2002-2008. She was also the Chair of the Thai
Board of Hematology during the same period. She has been on the editorial board
of the Thai Journal of Hematology. She was the Chair of the scientific subcommittee
for the Asia Pacific Division meeting of International Society of Hematology (ISH-APD
1999) in Bangkok in 1999. and the President of the 32nd World Congress of International
Society of Hematology (ISH 2008) in Bangkok in 2008. Professor Jootar has been elected
as the Chairman of councils of International Society of Hematology, her term starts
Professor Jootar has published numerous clinical research papers in leading national
and international peer-reviewed journals. Her main interest has been in the treatment
of chronic myeloid leukemia.
for CURRICULUM VITAE